What is the most common osteoporosis medication?

For both men and women at increased risk of fracture, the most widely prescribed osteoporosis medications are bisphosphonates. Examples include: Alendronate (Binosto, Fosamax) Ibandronate (Boniva)

Is Prolia better than bisphosphonates?

When it comes to improving bone density and reducing fracture risk, denosumab may provide better results than do bisphosphonates. As with bisphosphonates, it has a small risk of serious side effects, such as skin infections, headache and fatigue.

Is Reclast better than Fosamax?

Fosamax (alendronate) is a first-choice treatment for osteoporosis, but taking it can be a hassle. Prevents bone loss. Reclast (zoledronate) is a good choice for osteoporosis if you aren’t able to take bisphosphonates by mouth. It is available as a generic, but you have to see a doctor to get each dose.

What can I use instead of Prolia?

Are there alternatives to Reclast and Prolia for osteoporosis? There are several other medications that can be used to treat and/or prevent osteoporosis, such as: Other bisphosphonates besides Reclast: Examples of others include ibandronate (Boniva) and alendronate (Fosamax).

What can I take instead of Prolia?

Alternatives to Prolia

alendronate (Fosamax)
risedronate (Actonel)
ibandronate (Boniva)
zoledronic acid (Reclast, Zometa)
denosumab (Xgeva)
teriparatide (Forteo)
abaloparatide (Tymlos)
raloxifene (Evista)

Who should not take Tymlos?

Who should not take TYMLOS?

osteosarcoma of bone.
cancer metastasis to bone.
orthostatic hypotension, a form of low blood pressure.
Paget’s disease of bone.
stones in the urinary tract.
cancer that has spread to the bone from solid tumors.
high calcium blood level from hyperparathyroidism.

Which has more side effects Tymlos or Forteo?

Tymlos is marketed as a better version of Forteo, boasting that it reduces the relative risk of nonvertebral fractures by 43%. But, relative risk can be a deceivingly inflated statistic. In actuality, for both drugs there was just a 2-4% reduction in absolute risk of non vertebral fractures.